Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

PaperCitations, authors & open-access status

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 669 citations, 2019 year and closed oa status.

669
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Eduardo Flores‐Villalba
Author
Journal of the American College of Cardiology
Journal
Cardiovascular Function and Risk Factors
Topic
Cardiovascular Function and Risk Factors
Topic
Diabetes Treatment and Management
Topic
Bariatric Surgery and Outcomes
Topic
470M+ articles · free account